Lung Cancer Clinical Trials

Showing 161-180 of 2,032 trials

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

NCT06337552

The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients and non-small cell lung cancer (NSCLC) patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiation and NSCLC patients receiving immunotherapy.

Rectal CancerNon-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute54 participantsStarted Apr 2024

Tampa, Florida, United States

RECRUITINGPHASE1/PHASE2

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

NCT06706076

This Phase1/2, open label, multicenter study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics and preliminary anti-tumor activity of BH-30643 in patients with NSCLC having EGFR and/or HER2 mutations. Phase 1 will determine the recommended Phase 2 dose (RP2D) and, if applicable, the maximum tolerated dose (MTD) of BH-30643. Phase 2 will further evaluate the antitumor efficacy and safety in specified cohorts determined by EGFR/HER2 mutation subtypes and/or treatment history at the RP2D, as well as the population PK.

NSCLC (Advanced Non-small Cell Lung Cancer)

BlossomHill Therapeutics266 participantsStarted Jan 2025

Phoenix, Arizona, United States • Irvine, California, United States • La Jolla, California, United States +35 more locations

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Related Searches

Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer

Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.

Endobronchial Ultrasound-Guided Transbronchial Needle-Aspiration With Suction in Obtaining Samples From Patients With Suspected Nodal Metastatic Lung Cancer

Expanded Access to Telisotuzumab Vedotin

Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

A Phase II Study of SKB571 in Patients With Lung Cancer

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

A Study of MGC026 in Participants With Advanced Solid Tumors

Brain Oligometastasis in NSCLC

MPDL3280A With Chemoradiation for Lung Cancer

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Oxford Pleural Embolisation Trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy